292 related articles for article (PubMed ID: 31952493)
1. The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial.
Abdulla A; Ewoldt TMJ; Hunfeld NGM; Muller AE; Rietdijk WJR; Polinder S; van Gelder T; Endeman H; Koch BCP
BMC Infect Dis; 2020 Jan; 20(1):57. PubMed ID: 31952493
[TBL] [Abstract][Full Text] [Related]
2. Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT).
Abdulla A; Dijkstra A; Hunfeld NGM; Endeman H; Bahmany S; Ewoldt TMJ; Muller AE; van Gelder T; Gommers D; Koch BCP
Crit Care; 2020 Sep; 24(1):558. PubMed ID: 32933574
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring of β-lactam antibiotics in the ICU.
Dhaese S; Van Vooren S; Boelens J; De Waele J
Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1155-1164. PubMed ID: 32597263
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures.
Wong G; Briscoe S; McWhinney B; Ally M; Ungerer J; Lipman J; Roberts JA
J Antimicrob Chemother; 2018 Nov; 73(11):3087-3094. PubMed ID: 30137377
[TBL] [Abstract][Full Text] [Related]
5. A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III.
Lipman J; Brett SJ; De Waele JJ; Cotta MO; Davis JS; Finfer S; Glass P; Knowles S; McGuinness S; Myburgh J; Paterson DL; Peake S; Rajbhandari D; Rhodes A; Roberts JA; Shirwadkar C; Starr T; Taylor C; Billot L; Dulhunty JM
Crit Care Resusc; 2019 Mar; 21(1):63-68. PubMed ID: 30857514
[TBL] [Abstract][Full Text] [Related]
6. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
[TBL] [Abstract][Full Text] [Related]
7. An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.
Wong G; Brinkman A; Benefield RJ; Carlier M; De Waele JJ; El Helali N; Frey O; Harbarth S; Huttner A; McWhinney B; Misset B; Pea F; Preisenberger J; Roberts MS; Robertson TA; Roehr A; Sime FB; Taccone FS; Ungerer JP; Lipman J; Roberts JA
J Antimicrob Chemother; 2014 May; 69(5):1416-23. PubMed ID: 24443514
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic aspects of beta-lactam antibiotic therapy in intensive care unit patients: A one-center experience with TDM.
Sadilová K; Halačová M; Černý D
Ceska Slov Farm; 2020; 69(1):17-23. PubMed ID: 32460506
[TBL] [Abstract][Full Text] [Related]
9. Experience with Implementing a Beta-lactam Therapeutic Drug Monitoring Service in a Burn Intensive Care Unit: A Retrospective Chart Review.
Alshaer M; Mazirka P; Burch G; Peloquin C; Drabick Z; Carson J
J Burn Care Res; 2023 Jan; 44(1):121-128. PubMed ID: 35896122
[TBL] [Abstract][Full Text] [Related]
10. Barriers and facilitators for therapeutic drug monitoring of beta-lactams and ciprofloxacin in the ICU: a nationwide cross-sectional study.
Ewoldt TMJ; Abdulla A; van den Broek P; Hunfeld N; Bahmany S; Muller AE; Gommers D; Polinder S; Endeman H; Spronk I; Koch BCP
BMC Infect Dis; 2022 Jul; 22(1):611. PubMed ID: 35831793
[TBL] [Abstract][Full Text] [Related]
11. Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial.
Ewoldt TMJ; Abdulla A; Rietdijk WJR; Muller AE; de Winter BCM; Hunfeld NGM; Purmer IM; van Vliet P; Wils EJ; Haringman J; Draisma A; Rijpstra TA; Karakus A; Gommers D; Endeman H; Koch BCP
Intensive Care Med; 2022 Dec; 48(12):1760-1771. PubMed ID: 36350354
[TBL] [Abstract][Full Text] [Related]
12. The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France.
Charmillon A; Novy E; Agrinier N; Leone M; Kimmoun A; Levy B; Demoré B; Dellamonica J; Pulcini C
Clin Microbiol Infect; 2016 Jul; 22(7):625-31. PubMed ID: 27145210
[TBL] [Abstract][Full Text] [Related]
13. Barriers and Facilitators in the Clinical Implementation of Beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients: A Critical Review.
Abdulla A; van den Broek P; Ewoldt TMJ; Muller AE; Endeman H; Koch BCP
Ther Drug Monit; 2022 Feb; 44(1):112-120. PubMed ID: 34798631
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring of meropenem and piperacillin-tazobactam in the Singapore critically ill population - A prospective, multi-center, observational study (BLAST 1).
Chua NG; Loo L; Hee DKH; Lim TP; Ng TM; Hoo GSR; Soong JL; Ong JCL; Tang SSL; Zhou YP; Lee W; Lee LS; Cove M; Ling LM; Kwa AL
J Crit Care; 2022 Apr; 68():107-113. PubMed ID: 34999376
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of nine β-lactam antibiotics in human plasma by an ultrafast hydrophilic-interaction chromatography-tandem mass spectrometry.
Abdulla A; Bahmany S; Wijma RA; van der Nagel BCH; Koch BCP
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():138-143. PubMed ID: 28618388
[TBL] [Abstract][Full Text] [Related]
16. Beta-Lactam Antibiotic Therapeutic Drug Monitoring in Critically Ill Patients: A Systematic Review and Meta-Analysis.
Pai Mangalore R; Ashok A; Lee SJ; Romero L; Peel TN; Udy AA; Peleg AY
Clin Infect Dis; 2022 Nov; 75(10):1848-1860. PubMed ID: 35731853
[TBL] [Abstract][Full Text] [Related]
17. Protein binding of β-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations?
Wong G; Briscoe S; Adnan S; McWhinney B; Ungerer J; Lipman J; Roberts JA
Antimicrob Agents Chemother; 2013 Dec; 57(12):6165-70. PubMed ID: 24080664
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept.
Roberts JA; Ulldemolins M; Roberts MS; McWhinney B; Ungerer J; Paterson DL; Lipman J
Int J Antimicrob Agents; 2010 Oct; 36(4):332-9. PubMed ID: 20685085
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.
Veiga RP; Paiva JA
Crit Care; 2018 Sep; 22(1):233. PubMed ID: 30244674
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
Hagel S; Fiedler S; Hohn A; Brinkmann A; Frey OR; Hoyer H; Schlattmann P; Kiehntopf M; Roberts JA; Pletz MW;
Trials; 2019 Jun; 20(1):330. PubMed ID: 31171029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
